aluates Reports

$ 0.0

Automative

Global Aminoglycosides Antibiotics Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-17X5938

Global Aminoglycosides Antibiotics Drug Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Aminoglycosides Antibiotics Drug Market Research Report 2025

Code: QYRE-Auto-17X5938

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Jemicare

TEVA

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla Ltd

Pfizer Inc

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

Aminoglycosides Antibiotics Drug Market Size

The global market for Aminoglycosides Antibiotics Drug was valued at US$ 1075 million in the year 2024 and is projected to reach a revised size of US$ 1112 million by 2031, growing at a CAGR of 0.5% during the forecast period.

Aminoglycosides Antibiotics Drug Market

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Aminoglycosides Antibiotics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycosides Antibiotics Drug.

The Aminoglycosides Antibiotics Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aminoglycosides Antibiotics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aminoglycosides Antibiotics Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Aminoglycosides Antibiotics Drug Market Report

Report Metric	Details
Report Name	Aminoglycosides Antibiotics Drug Market
Accounted market size in year	US$ 1075 million
Forecasted market size in 2031	US$ 1112 million
CAGR	0.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Neomycin Tobramycin Gentamicin Amikacin Etimicin Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aminoglycosides Antibiotics Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Aminoglycosides Antibiotics Drug Market growing?

Ans: The Aminoglycosides Antibiotics Drug Market witnessing a CAGR of 0.5% during the forecast period 2025-2031.

What is the Aminoglycosides Antibiotics Drug Market size in 2031?

Ans: The Aminoglycosides Antibiotics Drug Market size in 2031 will be US$ 1112 million.

Who are the main players in the Aminoglycosides Antibiotics Drug Market report?

Ans: The main players in the Aminoglycosides Antibiotics Drug Market are Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company

What are the Application segmentation covered in the Aminoglycosides Antibiotics Drug Market report?

Ans: The Applications covered in the Aminoglycosides Antibiotics Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Aminoglycosides Antibiotics Drug Market report?

Ans: The Types covered in the Aminoglycosides Antibiotics Drug Market report are Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin, Others

Recommended Reports

Antibiotics and APIs

Infection and Disease Drugs

Diagnostics and Generics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Neomycin

1.2.3 Tobramycin

1.2.4 Gentamicin

1.2.5 Amikacin

1.2.6 Etimicin

1.2.7 Others

1.3 Market by Application

1.3.1 Global Aminoglycosides Antibiotics Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Aminoglycosides Antibiotics Drug Market Perspective (2020-2031)

2.2 Global Aminoglycosides Antibiotics Drug Growth Trends by Region

2.2.1 Global Aminoglycosides Antibiotics Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Aminoglycosides Antibiotics Drug Historic Market Size by Region (2020-2025)

2.2.3 Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2026-2031)

2.3 Aminoglycosides Antibiotics Drug Market Dynamics

2.3.1 Aminoglycosides Antibiotics Drug Industry Trends

2.3.2 Aminoglycosides Antibiotics Drug Market Drivers

2.3.3 Aminoglycosides Antibiotics Drug Market Challenges

2.3.4 Aminoglycosides Antibiotics Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Aminoglycosides Antibiotics Drug Players by Revenue

3.1.1 Global Top Aminoglycosides Antibiotics Drug Players by Revenue (2020-2025)

3.1.2 Global Aminoglycosides Antibiotics Drug Revenue Market Share by Players (2020-2025)

3.2 Global Aminoglycosides Antibiotics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Aminoglycosides Antibiotics Drug Revenue

3.4 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio

3.4.1 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Aminoglycosides Antibiotics Drug Revenue in 2024

3.5 Global Key Players of Aminoglycosides Antibiotics Drug Head office and Area Served

3.6 Global Key Players of Aminoglycosides Antibiotics Drug, Product and Application

3.7 Global Key Players of Aminoglycosides Antibiotics Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Aminoglycosides Antibiotics Drug Breakdown Data by Type

4.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Type (2020-2025)

4.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2026-2031)

5 Aminoglycosides Antibiotics Drug Breakdown Data by Application

5.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Application (2020-2025)

5.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Aminoglycosides Antibiotics Drug Market Size (2020-2031)

6.2 North America Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025)

6.4 North America Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Aminoglycosides Antibiotics Drug Market Size (2020-2031)

7.2 Europe Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025)

7.4 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size (2020-2031)

8.2 Asia-Pacific Aminoglycosides Antibiotics Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Aminoglycosides Antibiotics Drug Market Size (2020-2031)

9.2 Latin America Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025)

9.4 Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size (2020-2031)

10.2 Middle East & Africa Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Jemicare

11.1.1 Jemicare Company Details

11.1.2 Jemicare Business Overview

11.1.3 Jemicare Aminoglycosides Antibiotics Drug Introduction

11.1.4 Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.1.5 Jemicare Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Aminoglycosides Antibiotics Drug Introduction

11.2.4 Teva Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Aminoglycosides Antibiotics Drug Introduction

11.3.4 Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Fangyuan-pharma

11.4.1 Fangyuan-pharma Company Details

11.4.2 Fangyuan-pharma Business Overview

11.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Drug Introduction

11.4.4 Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.4.5 Fangyuan-pharma Recent Development

11.5 Aike Pharmaceutical

11.5.1 Aike Pharmaceutical Company Details

11.5.2 Aike Pharmaceutical Business Overview

11.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Introduction

11.5.4 Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.5.5 Aike Pharmaceutical Recent Development

11.6 Cipla

11.6.1 Cipla Company Details

11.6.2 Cipla Business Overview

11.6.3 Cipla Aminoglycosides Antibiotics Drug Introduction

11.6.4 Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.6.5 Cipla Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Aminoglycosides Antibiotics Drug Introduction

11.7.4 Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Fresenius Kabi

11.8.1 Fresenius Kabi Company Details

11.8.2 Fresenius Kabi Business Overview

11.8.3 Fresenius Kabi Aminoglycosides Antibiotics Drug Introduction

11.8.4 Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.8.5 Fresenius Kabi Recent Development

11.9 Sun Pharma

11.9.1 Sun Pharma Company Details

11.9.2 Sun Pharma Business Overview

11.9.3 Sun Pharma Aminoglycosides Antibiotics Drug Introduction

11.9.4 Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.9.5 Sun Pharma Recent Development

11.10 Hikma

11.10.1 Hikma Company Details

11.10.2 Hikma Business Overview

11.10.3 Hikma Aminoglycosides Antibiotics Drug Introduction

11.10.4 Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.10.5 Hikma Recent Development

11.11 Lannett Company

11.11.1 Lannett Company Company Details

11.11.2 Lannett Company Business Overview

11.11.3 Lannett Company Aminoglycosides Antibiotics Drug Introduction

11.11.4 Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025)

11.11.5 Lannett Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Jemicare

TEVA

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla Ltd

Pfizer Inc

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

List of Tables

Table 1. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Neomycin

Table 3. Key Players of Tobramycin

Table 4. Key Players of Gentamicin

Table 5. Key Players of Amikacin

Table 6. Key Players of Etimicin

Table 7. Key Players of Others

Table 8. Global Aminoglycosides Antibiotics Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Aminoglycosides Antibiotics Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Aminoglycosides Antibiotics Drug Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Aminoglycosides Antibiotics Drug Market Share by Region (2020-2025)

Table 12. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Aminoglycosides Antibiotics Drug Market Share by Region (2026-2031)

Table 14. Aminoglycosides Antibiotics Drug Market Trends

Table 15. Aminoglycosides Antibiotics Drug Market Drivers

Table 16. Aminoglycosides Antibiotics Drug Market Challenges

Table 17. Aminoglycosides Antibiotics Drug Market Restraints

Table 18. Global Aminoglycosides Antibiotics Drug Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Aminoglycosides Antibiotics Drug Market Share by Players (2020-2025)

Table 20. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2024)

Table 21. Ranking of Global Top Aminoglycosides Antibiotics Drug Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Aminoglycosides Antibiotics Drug Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Aminoglycosides Antibiotics Drug, Headquarters and Area Served

Table 24. Global Key Players of Aminoglycosides Antibiotics Drug, Product and Application

Table 25. Global Key Players of Aminoglycosides Antibiotics Drug, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Aminoglycosides Antibiotics Drug Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2020-2025)

Table 29. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2026-2031)

Table 31. Global Aminoglycosides Antibiotics Drug Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2020-2025)

Table 33. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2026-2031)

Table 35. North America Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 50. Jemicare Company Details

Table 51. Jemicare Business Overview

Table 52. Jemicare Aminoglycosides Antibiotics Drug Product

Table 53. Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 54. Jemicare Recent Development

Table 55. Teva Company Details

Table 56. Teva Business Overview

Table 57. Teva Aminoglycosides Antibiotics Drug Product

Table 58. Teva Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 59. Teva Recent Development

Table 60. Novartis Company Details

Table 61. Novartis Business Overview

Table 62. Novartis Aminoglycosides Antibiotics Drug Product

Table 63. Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 64. Novartis Recent Development

Table 65. Fangyuan-pharma Company Details

Table 66. Fangyuan-pharma Business Overview

Table 67. Fangyuan-pharma Aminoglycosides Antibiotics Drug Product

Table 68. Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 69. Fangyuan-pharma Recent Development

Table 70. Aike Pharmaceutical Company Details

Table 71. Aike Pharmaceutical Business Overview

Table 72. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product

Table 73. Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 74. Aike Pharmaceutical Recent Development

Table 75. Cipla Company Details

Table 76. Cipla Business Overview

Table 77. Cipla Aminoglycosides Antibiotics Drug Product

Table 78. Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 79. Cipla Recent Development

Table 80. Pfizer Company Details

Table 81. Pfizer Business Overview

Table 82. Pfizer Aminoglycosides Antibiotics Drug Product

Table 83. Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 84. Pfizer Recent Development

Table 85. Fresenius Kabi Company Details

Table 86. Fresenius Kabi Business Overview

Table 87. Fresenius Kabi Aminoglycosides Antibiotics Drug Product

Table 88. Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 89. Fresenius Kabi Recent Development

Table 90. Sun Pharma Company Details

Table 91. Sun Pharma Business Overview

Table 92. Sun Pharma Aminoglycosides Antibiotics Drug Product

Table 93. Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 94. Sun Pharma Recent Development

Table 95. Hikma Company Details

Table 96. Hikma Business Overview

Table 97. Hikma Aminoglycosides Antibiotics Drug Product

Table 98. Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 99. Hikma Recent Development

Table 100. Lannett Company Company Details

Table 101. Lannett Company Business Overview

Table 102. Lannett Company Aminoglycosides Antibiotics Drug Product

Table 103. Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2020-2025) & (US$ Million)

Table 104. Lannett Company Recent Development

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Authors List of This Report

List of Figures

Figure 1. Aminoglycosides Antibiotics Drug Picture

Figure 2. Global Aminoglycosides Antibiotics Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Aminoglycosides Antibiotics Drug Market Share by Type: 2024 VS 2031

Figure 4. Neomycin Features

Figure 5. Tobramycin Features

Figure 6. Gentamicin Features

Figure 7. Amikacin Features

Figure 8. Etimicin Features

Figure 9. Others Features

Figure 10. Global Aminoglycosides Antibiotics Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Aminoglycosides Antibiotics Drug Market Share by Application: 2024 VS 2031

Figure 12. Hospital Case Studies

Figure 13. Clinic Case Studies

Figure 14. Others Case Studies

Figure 15. Aminoglycosides Antibiotics Drug Report Years Considered

Figure 16. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Aminoglycosides Antibiotics Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Aminoglycosides Antibiotics Drug Market Share by Region: 2024 VS 2031

Figure 19. Global Aminoglycosides Antibiotics Drug Market Share by Players in 2024

Figure 20. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Aminoglycosides Antibiotics Drug Revenue in 2024

Figure 22. North America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Aminoglycosides Antibiotics Drug Market Share by Country (2020-2031)

Figure 24. United States Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2020-2031)

Figure 28. Germany Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share by Region (2020-2031)

Figure 36. China Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Aminoglycosides Antibiotics Drug Market Share by Country (2020-2031)

Figure 44. Mexico Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2020-2031)

Figure 48. Turkey Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Aminoglycosides Antibiotics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Jemicare Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 52. Teva Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 54. Fangyuan-pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 55. Aike Pharmaceutical Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 56. Cipla Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 58. Fresenius Kabi Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 59. Sun Pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 60. Hikma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 61. Lannett Company Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Aminoglycosides Antibiotics Market Research Report 2024

Global Aminoglycoside Antibiotics Market Research Report 2025

Liposomal Amikacin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tobramycin Sulfate Market Research Report 2024

Amoxicillin Antibiotic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Netilmicin Sulfate API Market Research Report 2024

Global Neomycin Sulfate API Market Research Report 2024

Ampicillin Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pediatric Antibiotics Market Research Report 2024

Global Gentamicin ELISA Kit Market Research Report 2024

Global Penicillin Streptomycin Gentamicin Solution Market Research Report 2025

Polypeptide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotic Resistance Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Systemic Antibiotics Market Research Report 2024

Polymixin B Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotics Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dihydrostreptomycin Sulfate Market Research Report 2024

Pets Antibiotic Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Amoxicillin Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions